Significance of apparent half-lives of a metabolite with a higher elimination rate than its parent drug.
| Autor: | Vree TB, Hekster CA, van der Kleijn E |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Drug intelligence & clinical pharmacy [Drug Intell Clin Pharm] 1982 Feb; Vol. 16 (2), pp. 126-31. |
| DOI: | 10.1177/106002808201600207 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|